Changchun BCHT Biotechnology Co.
Live Bioproducts Pharmaceutical,Live High Potency Medicine,Live Preventive Pharmaceutical,Varicella Biopharmaceutical Live
1.Good safety of gelatin-free.The first lyophilized Varicella Vaccine, containing no gelatin from animals, invented and produced in China. Getting rid of gelatin from varicella vaccine can significantly decrease the ratio of anaphylaxis incidence .
2.Long validity period by good stability. The first approved varicella vaccine with 36 months of validity period in the world. Adopting BH-2 stabilizer with own IP rights (Chinese patent granted No.: ZL200910138411.6, International patent application No.: PCT/CN2009/001405) greatly enhances the stability of the product and ensures the validity period for 36 months under the storage condition.
3.Better protection with high titer and immune efficacy. It`s documented that compared with the varicella vaccine of low titer, high titer vaccine can reduce breakthrough cases by nearly 75% in vaccination. Of all released batches of Varicella Vaccine from BCHT, the titers are not less than 10000 PFU/dose tested by National Institutes for Food and Drug Control.